![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 239/95 | (2006.01) |
A61K 31/517 | (2006.01) | ||
A61P 1/16 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 31/12 | (2006.01) |
(11) | Number of the document | 3759083 |
(13) | Kind of document | T |
(96) | European patent application number | 19708817.2 |
Date of filing the European patent application | 2019-02-28 | |
(97) | Date of publication of the European application | 2021-01-06 |
(45) | Date of publication and mention of the grant of the patent | 2022-05-04 |
(46) | Date of publication of the claims translation | 2022-07-11 |
(86) | Number | PCT/EP2019/054941 |
Date | 2019-02-28 |
(87) | Number | WO 2019/166532 |
Date | 2019-09-06 |
(30) | Number | Date | Country code |
18159583 | 2018-03-01 | EP |
(72) |
MC GOWAN, David, Craig , BE
EMBRECHTS, Werner, Constant, Johan , BE
GUILLEMONT, Jérôme, Émile, Georges , FR
COOYMANS, Ludwig, Paul , BE
JONCKERS, Tim, Hugo, Maria , BE
RABOISSON, Pierre, Jean-Marie, Bernard , BE
|
(73) |
Janssen Sciences Ireland Unlimited Company ,
Barnahely, Ringaskiddy, Co Cork,
IE
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | 2,4-Diaminochinazolino dariniai ir jų naudojimas virusinės infekcijos, vėžio ir alergijų gydymui |
2,4-DIAMINOQUINAZOLINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRUS INFECTIONS, CANCER OR ALLERGIES |
Payment date | Validity (years) | Amount | |
2024-01-30 | 6 | 139.00 EUR |
2025-02-28 |